Agoracom Blog

@Novamind_Inc $ Weekly Roundup $ $MMED $ $ $CMPS $

Posted by AGORACOM-JC at 11:39 AM on Saturday, February 13th, 2021

A weekly summary of Novamind news and media

FEATURES February 7, 2021

Novamind’s Dr. Reid Robison on Building a Network for Psychedelic Medicine

With years of experience studying and administering ketamine, Dr. Robison discusses psychedelic infrastructure and the change it can create

FEATURES February 7, 2021

Therapy with Substance

There are millions of people who have been diagnosed with a mental health issue that are resistant to the current range of available treatments.

View all media

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

February 11, 2021

View all press releases

Follow @novamind_inc on Instagram

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit

Tags: , , , , , ,

Comments are closed.